| You are in:Home/Publications/Plasma Thymus & Activation-Regulated Chemokine (TARC) and Monocyte-Derived Chemokine (MDC) levels in Chronic Asthmatic Patients developed Acute Exacerbation | |
Prof. Ali Elsayed Ali Hasaneen :: Publications: |
|
| Title: | Plasma Thymus & Activation-Regulated Chemokine (TARC) and Monocyte-Derived Chemokine (MDC) levels in Chronic Asthmatic Patients developed Acute Exacerbation |
| Authors: | Gamal Eliwa *, Samir A. Elsharkawy** and Ali Hasaneen** |
| Year: | 2011 |
| Keywords: | Not Available |
| Journal: | Not Available |
| Volume: | Not Available |
| Issue: | Not Available |
| Pages: | Not Available |
| Publisher: | Not Available |
| Local/International: | International |
| Paper Link: | Not Available |
| Full paper | Ali Elsayed Ali Hasaneen_paper 3.doc |
| Supplementary materials | Not Available |
| Abstract: |
Objectives: The present study was designed to measure the plasma levels of Thymus and activation-regulated chemokine (TARC) and monocyte-derived chemokine (MDC) in chronic asthmatic patients required hospitalization for acute exacerbation. Patients & Methods: The study included 40 patients; 29 males and 11 females with mean age 49.7±7 years. All patients had acute exacerbation of chronic bronchial asthma, and underwent clinical and radiological evaluation. Venous blood samples were obtained at time of admission (Day-0) and 4-weeks after inclusion in the study (Day-28) for ELISA estimation of plasma levels of TARC and MDC. Results: Mean plasma levels of TARC estimated at time of admission (78.9±30.6; range: 43-175 pg/ml) were significantly higher (p |
